interleukin-1beta (163-171) has been researched along with Neuroblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Morante, D; Cortes-Canteli, M; Gine, E; Hernandez-Encinas, E; Morales-Garcia, JA; Perez-Castillo, A; Santos, A | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and Neuroblastoma
Article | Year |
---|---|
CCAAT/enhancer binding protein β directly regulates the expression of the complement component 3 gene in neural cells: implications for the pro-inflammatory effects of this transcription factor.
Topics: Animals; Animals, Newborn; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Cells, Cultured; Complement C3; Cyclooxygenase 2; Gene Expression Regulation; Hippocampus; Interleukin-1beta; Male; Mice; Mice, Transgenic; Microarray Analysis; Neuroblastoma; Neuroglia; Neurons; Peptide Fragments; Polysaccharides; Rats; Rats, Wistar | 2015 |